{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:39:43Z","timestamp":1780969183402,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,6]]},"DOI":"10.7759\/cureus.66295","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T16:54:02Z","timestamp":1722963242000},"source":"Crossref","is-referenced-by-count":1,"title":["In Vitro Synergistic Effect of Colistin with Fosfomycin Against Carbapenem-Resistant Klebsiella pneumoniae"],"prefix":"10.7759","author":[{"given":"Chethankumar","family":"P","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejashree","family":"A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetha  S","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morubagal","family":"Raghavendra Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24743","article-title":"The making of hypervirulent Klebsiella pneumoniae","volume":"36","author":"Dai P","year":"2022","unstructured":"Dai P, Hu D. The making of hypervirulent Klebsiella pneumoniae. J Clin Lab Anal. 2022, 36:e24743. 10.1002\/jcla.24743","journal-title":"J Clin Lab Anal"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10060736","article-title":"The synergistic activity and optimizing doses of tigecycline in combination with aminoglycosides against clinical carbapenem-resistant Klebsiella pneumoniae isolates","volume":"10","author":"Nulsopapon P","year":"2021","unstructured":"Nulsopapon P, Nasomsong W, Pongchaidecha M, Changpradub D, Juntanawiwat P, Santimaleeworagun W. The synergistic activity and optimizing doses of tigecycline in combination with aminoglycosides against clinical carbapenem-resistant Klebsiella pneumoniae isolates. Antibiotics (Basel). 2021, 10:736. 10.3390\/antibiotics10060736","journal-title":"Antibiotics (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-017-0191-3","article-title":"Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae","volume":"16","author":"Xu L","year":"2017","unstructured":"Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017, 16:18. 10.1186\/s12941-017-0191-3","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.04.004","article-title":"In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains","volume":"76","author":"Evren E","year":"2013","unstructured":"Evren E, Azap OK, \u00c7olako\u011flu \u015e, Arslan H. In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains. Diagn Microbiol Infect Dis. 2013, 76:335-8. 10.1016\/j.diagmicrobio.2013.04.004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S292431","article-title":"In vitro and in vivo effect of antimicrobial agent combinations against carbapenem-resistant Klebsiella pneumoniae with different resistance mechanisms in China","volume":"14","author":"Liu E","year":"2021","unstructured":"Liu E, Jia P, Li X, et al.. In vitro and in vivo effect of antimicrobial agent combinations against carbapenem-resistant Klebsiella pneumoniae with different resistance mechanisms in China. Infect Drug Resist. 2021, 14:917-28. 10.2147\/IDR.S292431","journal-title":"Infect Drug Resist"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5720417","article-title":"Synergistic activity of colistin\/fosfomycin combination against carbapenemase-producing Klebsiella pneumoniae in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"2018","author":"Wang J","year":"2018","unstructured":"Wang J, He JT, Bai Y, Wang R, Cai Y. Synergistic activity of colistin\/fosfomycin combination against carbapenemase-producing Klebsiella pneumoniae in an in vitro pharmacokinetic\/pharmacodynamic model. Biomed Res Int. 2018, 2018:5720417. 10.1155\/2018\/5720417","journal-title":"Biomed Res Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11111646","article-title":"Evaluation of in vitro activity of double-carbapenem combinations against KPC-2-, OXA-48-and NDM-producing Escherichia coli and Klebsiella pneumoniae","volume":"11","author":"Allander L","year":"2022","unstructured":"Allander L, Vickberg K, Lagerb\u00e4ck P, Sandegren L, T\u00e4ngd\u00e9n T. Evaluation of in vitro activity of double-carbapenem combinations against KPC-2-, OXA-48-and NDM-producing Escherichia coli and Klebsiella pneumoniae. Antibiotics (Basel). 2022, 11:1646. 10.3390\/antibiotics11111646","journal-title":"Antibiotics (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2017.04.015","article-title":"Synergistic activities of meropenem double and triple combinations against carbapenemase-producing Enterobacteriaceae","volume":"88","author":"Fredborg M","year":"2017","unstructured":"Fredborg M, Sondergaard TE, Wang M. Synergistic activities of meropenem double and triple combinations against carbapenemase-producing Enterobacteriaceae. Diagn Microbiol Infect Dis. 2017, 88:355-60. 10.1016\/j.diagmicrobio.2017.04.015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2018.0234","article-title":"Activity of ceftazidime-avibactam alone and in combination with ertapenem, fosfomycin, and tigecycline against carbapenemase-producing Klebsiella pneumoniae","volume":"25","author":"Ojdana D","year":"2019","unstructured":"Ojdana D, Gutowska A, Sacha P, Majewski P, Wieczorek P, Tryniszewska E. Activity of ceftazidime-avibactam alone and in combination with ertapenem, fosfomycin, and tigecycline against carbapenemase-producing Klebsiella pneumoniae. Microb Drug Resist. 2019, 25:1357-64. 10.1089\/mdr.2018.0234","journal-title":"Microb Drug Resist"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2019-0074","article-title":"Synergistic activity of fosfomycin-meropenem and fosfomycin-colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence","volume":"6","author":"Bakthavatchalam YD","year":"2020","unstructured":"Bakthavatchalam YD, Shankar A, Muthuirulandi Sethuvel DP, Asokan K, Kanthan K, Veeraraghavan B. Synergistic activity of fosfomycin-meropenem and fosfomycin-colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence. Future Sci OA. 2020, 6:FSO461. 10.2144\/fsoa-2019-0074","journal-title":"Future Sci OA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2020.11.004","article-title":"In\u00a0vitro synergistic activity of fosfomycin in combination with other antimicrobial agents against carbapenem-resistant Klebsiella pneumoniae isolated from patients in a hospital in Thailand","volume":"27","author":"Chukamnerd A","year":"2021","unstructured":"Chukamnerd A, Pomwised R, Paing Phoo MT, Terbtothakun P, Hortiwakul T, Charoenmak B, Chusri S. In\u00a0vitro synergistic activity of fosfomycin in combination with other antimicrobial agents against carbapenem-resistant Klebsiella pneumoniae isolated from patients in a hospital in Thailand. J Infect Chemother. 2021, 27:507-14. 10.1016\/j.jiac.2020.11.004","journal-title":"J Infect Chemother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.12.019","article-title":"Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae","volume":"22","author":"Liu P","year":"2020","unstructured":"Liu P, Chen S, Wu ZY, Qi M, Li XY, Liu CX. Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae. J Glob Antimicrob Resist. 2020, 22:238-43. 10.1016\/j.jgar.2019.12.019","journal-title":"J Glob Antimicrob Resist"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S408228","article-title":"In vitro synergistic activity of ceftazidime-avibactam in combination with aztreonam or meropenem against clinical Enterobacterales producing Bla(KPC) or Bla(NDM)","volume":"16","author":"Kuai J","year":"2023","unstructured":"Kuai J, Zhang Y, Lu B, et al.. In vitro synergistic activity of ceftazidime-avibactam in combination with aztreonam or meropenem against clinical Enterobacterales producing Bla(KPC) or Bla(NDM). Infect Drug Resist. 2023, 16:3171-82. 10.2147\/IDR.S408228","journal-title":"Infect Drug Resist"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2020.10.018","article-title":"In-vitro synergistic activity of colistin and meropenem against clinical isolates of carbapenem resistant E.coli and Klebsiella pneumoniae by checkerboard method","volume":"39","author":"Dhandapani S","year":"2021","unstructured":"Dhandapani S, Sistla S, Gunalan A, Manoharan M, Sugumar M, Sastry AS. In-vitro synergistic activity of colistin and meropenem against clinical isolates of carbapenem resistant E.coli and Klebsiella pneumoniae by checkerboard method. Indian J Med Microbiol. 2021, 39:6-10. 10.1016\/j.ijmmb.2020.10.018","journal-title":"Indian J Med Microbiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2019-0032","article-title":"Synergistic effect of doripenem in combination with cefoxitin and tetracycline in inhibiting NDM-1 producing bacteria","volume":"14","author":"Maryam L","year":"2019","unstructured":"Maryam L, Khalid S, Ali A, Khan AU. Synergistic effect of doripenem in combination with cefoxitin and tetracycline in inhibiting NDM-1 producing bacteria. Future Microbiol. 2019, 14:671-89. 10.2217\/fmb-2019-0032","journal-title":"Future Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(93)90087-n","article-title":"Synergy assessed by checkerboard. A critical analysis","volume":"16","author":"Hsieh MH","year":"1993","unstructured":"Hsieh MH, Yu CM, Yu VL, Chow JW. Synergy assessed by checkerboard. A critical analysis. Diagn Microbiol Infect Dis. 1993, 16:343-9. 10.1016\/0732-8893(93)90087-n","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0732-8893(02)00473-x","article-title":"Comparison of methods of interpretation of checkerboard synergy testing","volume":"44","author":"Bonapace CR","year":"2002","unstructured":"Bonapace CR, Bosso JA, Friedrich LV, White RL. Comparison of methods of interpretation of checkerboard synergy testing. Diagn Microbiol Infect Dis. 2002, 44:363-6. 10.1016\/s0732-8893(02)00473-x","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/ijmm.IJMM_17_189","article-title":"An update on technical, interpretative and clinical relevance of antimicrobial synergy testing methodologies","volume":"35","author":"Laishram S","year":"2017","unstructured":"Laishram S, Pragasam AK, Bakthavatchalam YD, Veeraraghavan B. An update on technical, interpretative and clinical relevance of antimicrobial synergy testing methodologies. Indian J Med Microbiol. 2017, 35:445-68. 10.4103\/ijmm.IJMM_17_189","journal-title":"Indian J Med Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S397975","article-title":"Molecular and clinical characteristics of carbapenem-resistant Klebsiella pneumoniae isolates at a tertiary hospital in Wuhan, China","volume":"16","author":"Hu F","year":"2023","unstructured":"Hu F, Lin ML, Mou JL, et al.. Molecular and clinical characteristics of carbapenem-resistant Klebsiella pneumoniae isolates at a tertiary hospital in Wuhan, China. Infect Drug Resist. 2023, 16:65-76. 10.2147\/IDR.S397975","journal-title":"Infect Drug Resist"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S282386","article-title":"Analysis of the clinical effect of combined drug susceptibility to guide medication for carbapenem-resistant Klebsiella pneumoniae patients based on the kirby-bauer disk diffusion method","volume":"14","author":"Yao H","year":"2021","unstructured":"Yao H, Liu J, Jiang X, Chen F, Lu X, Zhang J. Analysis of the clinical effect of combined drug susceptibility to guide medication for carbapenem-resistant Klebsiella pneumoniae patients based on the kirby-bauer disk diffusion method. Infect Drug Resist. 2021, 14:79-87. 10.2147\/IDR.S282386","journal-title":"Infect Drug Resist"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10121552","article-title":"Synergistic combination of AS101 and azidothymidine against clinical isolates of carbapenem-resistant Klebsiella pneumoniae","volume":"10","author":"Sung CL","year":"2021","unstructured":"Sung CL, Hung WC, Lu PL, Lin L, Wang LC, Yang TY, Tseng SP. Synergistic combination of AS101 and azidothymidine against clinical isolates of carbapenem-resistant Klebsiella pneumoniae. Pathogens. 2021, 10:1552. 10.3390\/pathogens10121552","journal-title":"Pathogens"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/1120009X.2020.1745501","article-title":"In vitro synergistic activity of fosfomycin in combination with meropenem, amikacin and colistin against OXA-48 and\/or NDM-producing Klebsiella pneumoniae","volume":"32","author":"Erturk Sengel B","year":"2020","unstructured":"Erturk Sengel B, Altinkanat Gelmez G, Soyletir G, Korten V. In vitro synergistic activity of fosfomycin in combination with meropenem, amikacin and colistin against OXA-48 and\/or NDM-producing Klebsiella pneumoniae. J Chemother. 2020, 32:237-43. 10.1080\/1120009X.2020.1745501","journal-title":"J Chemother"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12020237","article-title":"In vitro and in vivo synergism of fosfomycin in combination with meropenem or polymyxin B against KPC-2-producing Klebsiella pneumoniae clinical isolates","volume":"12","author":"Ribeiro AC","year":"2023","unstructured":"Ribeiro AC, Chikhani YC, Valiatti TB, et al.. In vitro and in vivo synergism of fosfomycin in combination with meropenem or polymyxin B against KPC-2-producing Klebsiella pneumoniae clinical isolates. Antibiotics (Basel). 2023, 12:237. 10.3390\/antibiotics12020237","journal-title":"Antibiotics (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02357-18","article-title":"Dose-dependent synergistic interactions of colistin with rifampin, meropenem, and tigecycline against carbapenem-resistant Klebsiella pneumoniae biofilms","volume":"63","author":"Geladari A","year":"2019","unstructured":"Geladari A, Simitsopoulou M, Antachopoulos C, Roilides E. Dose-dependent synergistic interactions of colistin with rifampin, meropenem, and tigecycline against carbapenem-resistant Klebsiella pneumoniae biofilms. Antimicrob Agents Chemother. 2019, 63:e02357-18. 10.1128\/AAC.02357-18","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244673","article-title":"Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates","volume":"16","author":"Ontong JC","year":"2021","unstructured":"Ontong JC, Ozioma NF, Voravuthikunchai SP, Chusri S. Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates. PLoS One. 2021, 16:e0244673. 10.1371\/journal.pone.0244673","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/276535-in-vitro-synergistic-effect-of-colistin-with-fosfomycin-against-carbapenem-resistant-klebsiella-pneumoniae","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T16:54:08Z","timestamp":1722963248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/276535-in-vitro-synergistic-effect-of-colistin-with-fosfomycin-against-carbapenem-resistant-klebsiella-pneumoniae"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.66295","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,6]]}}}